<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A method for determining antithrombin-III <z:chebi fb="5" ids="28304">heparin</z:chebi> cofactor activity that requires no defibrinogenation of plasma, can be used with heparinized samples, and is specific for antithrombin-III <z:chebi fb="5" ids="28304">heparin</z:chebi> cofactor activity was developed </plain></SENT>
<SENT sid="1" pm="."><plain>The procedure requires minimal pipetting, uses small amounts of sample over a single short incubation period, and is relatively inexpensive </plain></SENT>
<SENT sid="2" pm="."><plain>The antithrombin-III assay appears to be superior to other commercially available procedures when employed in the diagnosis of deficiencies and in the identification of decreased levels of antithrombin III associated with <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> and thrombotic disorders </plain></SENT>
</text></document>